{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:12:27Z","timestamp":1779264747504,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine adherence and safety of a diagnostic (culture, urinalysis) and therapeutic (5-day antibiotic course with a time-out) guideline for urinary tract infection (UTI) in the Neonatal Intensive Care Unit<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Prospective surveillance of non-bacteremic UTIs from 11\/2020-12\/2022. Safety outcomes were defined by re-initiation of antibiotics within 7 days for a subsequent UTI due to the same organism and overall and UTI-related mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>77 infants received treatment for 93 UTIs with 77% (72\/93) adherence to diagnostic criteria; 90% (82\/91) of infants received \u22646 days of definitive treatment (median [IQR] antibiotic duration 5 [5\u20136] days). Antibiotics were restarted within 7 days for a recurrent (same organism) UTI in 1\/91 (1%) UTIs. Mortality was 4% (4\/93); none were due to UTI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adherence to diagnostic UTI criteria was 77%. 90% of infants received short course treatment that was associated with a 1% failure rate. No safety concern was identified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41372-026-02690-1","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:18:50Z","timestamp":1777454330000},"page":"754-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary tract infection in the neonatal intensive care unit"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-8157","authenticated-orcid":false,"given":"Jacqueline","family":"Magers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Prusakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie O.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-6129","authenticated-orcid":false,"given":"Randy R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Moraille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Theile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1247","authenticated-orcid":false,"given":"Pablo J.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Nationwide Children\u2019s Hospital Neonatal Antimicrobial Stewardship Program (NEO-ASP)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo J.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline K.","family":"Magers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua R.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Taveras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Albertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Yin Mandy","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy Nathaniel","family":"Johnson-Roddenberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jebbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maclain J.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopali","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2690_CR1","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1542\/neo.19-6-e337","volume":"19","author":"A Lai","year":"2018","unstructured":"Lai A, Rove KO, Amin S, Vricella GJ, Coplen DE. Diagnosis and management of urinary tract infections in premature and term infants. NeoReviews. 2018;19:e337\u2013e48.","journal-title":"NeoReviews"},{"key":"2690_CR2","doi-asserted-by":"publisher","first-page":"e2202","DOI":"10.1055\/s-0043-1771015","volume":"41","author":"R Kilpatrick","year":"2024","unstructured":"Kilpatrick R, Boutzoukas AE, Chan E, Girgis V, Kinduelo V, Kwabia SA, et al. Urinary tract infection epidemiology in NICUs in the United States. Am J Perinatol. 2024;41:e2202\u2013e8.","journal-title":"Am J Perinatol"},{"key":"2690_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41372-018-0226-4","volume":"39","author":"CM Drumm","year":"2019","unstructured":"Drumm CM, Siddiqui JN, Desale S, Ramasethu J. Urinary tract infection is common in VLBW infants. J Perinatol. 2019;39:80\u20135.","journal-title":"J Perinatol"},{"key":"2690_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41372-025-02337-7","volume":"45","author":"Y Nishihara","year":"2025","unstructured":"Nishihara Y, Zaniletti I, Zenge J, Weikel B, Parker S, Murthy K, et al. Epidemiology of bacterial and fungal infections among level IV neonatal units in North America. J Perinatol. 2025;45:997\u20131004.","journal-title":"J Perinatol"},{"key":"2690_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/NPM-16915055","volume":"9","author":"C Ruangkit","year":"2016","unstructured":"Ruangkit C, Satpute A, Vogt BA, Hoyen C, Viswanathan S. Incidence and risk factors of urinary tract infection in very low birth weight infants. J Neonatal Perinatal Med. 2016;9:83\u201390.","journal-title":"J Neonatal Perinatal Med"},{"key":"2690_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41372-024-01951-1","volume":"44","author":"A Abda","year":"2024","unstructured":"Abda A, Panetta L, Blackburn J, Chevalier I, Lachance C, Ovetchkine P, et al. Urinary tract infections in very premature neonates: the definition dilemma. J Perinatol. 2024;44:731\u20138.","journal-title":"J Perinatol"},{"key":"2690_CR7","first-page":"695","volume":"32","author":"MF Weems","year":"2015","unstructured":"Weems MF, Wei D, Ramanathan R, Barton L, Vachon L, Sardesai S. Urinary tract infections in a neonatal intensive care unit. Am J Perinatol. 2015;32:695\u2013702.","journal-title":"Am J Perinatol"},{"key":"2690_CR8","first-page":"6","volume":"138","author":"Subcommittee on Urinary Tract I","year":"2016","unstructured":"Subcommittee on Urinary Tract I. Reaffirmation of AAP clinical practice guideline: the diagnosis and management of the initial urinary tract infection in febrile infants and young children 2-24 months of age. Pediatrics. 2016;138:6.","journal-title":"Pediatrics"},{"key":"2690_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jiph.2010.09.003","volume":"3","author":"D Clarke","year":"2010","unstructured":"Clarke D, Gowrishankar M, Etches P, Lee BE, Robinson JL. Management and outcome of positive urine cultures in a neonatal intensive care unit. J Infect Public Health. 2010;3:152\u20138.","journal-title":"J Infect Public Health"},{"key":"2690_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41372-021-01079-6","volume":"41","author":"DP Gorski","year":"2021","unstructured":"Gorski DP, Bauer AS, Menda NS, Harer MW. Treatment of positive urine cultures in the neonatal intensive care unit: a guideline to reduce antibiotic utilization. J Perinatol. 2021;41:1474\u20139.","journal-title":"J Perinatol"},{"key":"2690_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.12788\/jhm.3349","volume":"15","author":"PW Chang","year":"2020","unstructured":"Chang PW, Wang ME, Schroeder AR. Diagnosis and management of UTI in febrile infants age 0-2 months: applicability of the AAP guideline. J Hosp Med. 2020;15:e1\u2013e5.","journal-title":"J Hosp Med"},{"key":"2690_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"2690_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"2690_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1542\/peds.2021-052360","volume":"149","author":"J Magers","year":"2022","unstructured":"Magers J, Prusakov P, Speaks S, Conroy S, Sanchez PJ. Safety and efficacy of nafcillin for empiric therapy of late-onset sepsis in the NICU. Pediatrics. 2022;149:5.","journal-title":"Pediatrics"},{"key":"2690_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/NPM-230101","volume":"17","author":"B Krasity","year":"2024","unstructured":"Krasity B, Hasan M, Uppuluri S, Prazad P. Standardization of urinary tract infection diagnosis in the neonatal ICU: experience at a tertiary care center. J Neonatal Perinatal Med. 2024;17:13\u201320.","journal-title":"J Neonatal Perinatal Med"},{"key":"2690_CR16","doi-asserted-by":"crossref","unstructured":"Mattoo TK, Shaikh N, Nelson CP. Contemporary management of urinary tract infection in children. Pediatrics. 2021;147:e2020012138.","DOI":"10.1542\/peds.2020-012138"},{"key":"2690_CR17","first-page":"70","volume":"61","author":"AJ Rahman","year":"2011","unstructured":"Rahman AJ, Naz F, Ashraf S. Significance of pyuria in the diagnosis of urinary tract infections in neonates. J Pak Med Assoc. 2011;61:70\u20133.","journal-title":"J Pak Med Assoc"},{"key":"2690_CR18","doi-asserted-by":"crossref","unstructured":"Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O\u2019Leary ST, et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148:e2021052228.","DOI":"10.1542\/peds.2021-052228"},{"key":"2690_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamapediatrics.2023.1979","volume":"177","author":"T Zaoutis","year":"2023","unstructured":"Zaoutis T, Shaikh N, Fisher BT, Coffin SE, Bhatnagar S, Downes KJ, et al. Short-course therapy for urinary tract infections in children: the SCOUT randomized clinical trial. JAMA Pediatr. 2023;177:782\u20139.","journal-title":"JAMA Pediatr"},{"key":"2690_CR20","doi-asserted-by":"crossref","unstructured":"Montini G, Tessitore A, Console K, Ronfani L, Barbi E, Pennesi M, et al. Short oral antibiotic therapy for pediatric febrile urinary tract infections: a randomized trial. Pediatrics. 2024;153:e2023062598.","DOI":"10.1542\/peds.2023-062598"},{"key":"2690_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1473-3099(25)00075-1","volume":"25","author":"NJ Sethi","year":"2025","unstructured":"Sethi NJ, Carlsen ELM, Tabassum A, Cortes D, Mark Ow S, Schmidt IM, et al. Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): a pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in Denmark. Lancet Infect Dis. 2025;25:925\u201335.","journal-title":"Lancet Infect Dis"},{"key":"2690_CR22","first-page":"316","volume":"29","author":"K Van","year":"2024","unstructured":"Van K, Patel PH, Jones K, Jackson C, Faddoul N, Pulickal A. Association between antibiotic duration and recurrence of urinary tract infection in the neonatal critical care unit. J Pediatr Pharmacol Ther. 2024;29:316\u201322.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2690_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1542\/peds.2021-052466","volume":"149","author":"S Hikmat","year":"2022","unstructured":"Hikmat S, Lawrence J, Gwee A. Short intravenous antibiotic courses for urinary infections in young infants: a systematic review. Pediatrics. 2022;149:2.","journal-title":"Pediatrics"},{"key":"2690_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1542\/hpeds.2021-005877","volume":"11","author":"N Nama","year":"2021","unstructured":"Nama N, Donken R, Pawliuk C, Leache L, Sadarangani M, Carwana M, et al. Treatment of UTIs in infants <2 months: a living systematic review. Hosp Pediatr. 2021;11:1017\u201330.","journal-title":"Hosp Pediatr"},{"key":"2690_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.idc.2014.01.005","volume":"28","author":"JB Cantey","year":"2014","unstructured":"Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28:247\u201361.","journal-title":"Infect Dis Clin North Am"},{"key":"2690_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jamapediatrics.2016.2132","volume":"170","author":"JY Ting","year":"2016","unstructured":"Ting JY, Synnes A, Roberts A, Deshpandey A, Dow K, Yoon EW, et al. Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr. 2016;170:1181\u20137.","journal-title":"JAMA Pediatr"},{"key":"2690_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jpeds.2016.11.002","volume":"181","author":"JB Cantey","year":"2017","unstructured":"Cantey JB, Huffman LW, Subramanian A, Marshall AS, Ballard AR, Lefevre C, et al. Antibiotic exposure and risk for death or bronchopulmonary dysplasia in very low birth weight infants. J Pediatr. 2017;181:289\u201393 e1.","journal-title":"J Pediatr"},{"key":"2690_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0248-8","volume":"5","author":"M Pammi","year":"2017","unstructured":"Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome. 2017;5:31.","journal-title":"Microbiome"},{"key":"2690_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2020.151323","volume":"44","author":"T Wang","year":"2020","unstructured":"Wang T, Udomkittivorakul N, Bonfield M, Nadeem A, Gray J, Deshmukh H. Early life antibiotic exposure and host health: role of the microbiota-immune interaction. Semin Perinatol. 2020;44:151323.","journal-title":"Semin Perinatol"},{"key":"2690_CR30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/08850666241258386","volume":"40","author":"DD Flannery","year":"2025","unstructured":"Flannery DD, Coggins SA, Medoro AK. Antibiotic stewardship in the neonatal intensive care unit. J Intensive Care Med. 2025;40:862\u201375.","journal-title":"J Intensive Care Med"},{"key":"2690_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpeds.2018.07.036","volume":"203","author":"JB Cantey","year":"2018","unstructured":"Cantey JB, Pyle AK, Wozniak PS, Hynan LS, Sanchez PJ. Early antibiotic exposure and adverse outcomes in preterm, very low birth weight infants. J Pediatr. 2018;203:62\u20137.","journal-title":"J Pediatr"},{"key":"2690_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1542\/peds.2018-2286","volume":"143","author":"JY Ting","year":"2019","unstructured":"Ting JY, Roberts A, Sherlock R, Ojah C, Cieslak Z, Dunn M, et al. Duration of initial empirical antibiotic therapy and outcomes in very low birth weight infants. Pediatrics. 2019;143:3.","journal-title":"Pediatrics"},{"key":"2690_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41372-023-01720-6","volume":"43","author":"ZS Lewald","year":"2023","unstructured":"Lewald ZS, Prusakov P, Magers JK, Kielt MJ, de Alba Romero C, White NO, et al. Short-course antibiotic therapy for pneumonia in the neonatal intensive care unit. J Perinatol. 2023;43:1145\u201351.","journal-title":"J Perinatol"},{"key":"2690_CR34","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S1473-3099(16)30205-5","volume":"16","author":"JB Cantey","year":"2016","unstructured":"Cantey JB, Wozniak PS, Pruszynski JE, Sanchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16:1178\u201384.","journal-title":"Lancet Infect Dis"},{"key":"2690_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107158","volume":"146","author":"A Dramowski","year":"2024","unstructured":"Dramowski A, Prusakov P, Goff DA, Brink A, Govender NP, Annor AS, et al. Prospective antimicrobial stewardship interventions by multidisciplinary teams to reduce neonatal antibiotic use in South Africa: the Neonatal Antimicrobial Stewardship (NeoAMS) study. Int J Infect Dis. 2024;146:107158.","journal-title":"Int J Infect Dis"},{"key":"2690_CR36","doi-asserted-by":"crossref","unstructured":"Djordjevich CJ, Magers J, Cantey JB, Prusakov P, Sanchez PJ. Duration of antibiotic therapy for gram-negative bloodstream infections in the neonatal intensive care unit. J Pediatr. 2026;292:114993.","DOI":"10.1016\/j.jpeds.2026.114993"},{"key":"2690_CR37","doi-asserted-by":"crossref","unstructured":"Roberts KB, Wald ER. The diagnosis of UTI: colony count criteria revisited. Pediatrics. 2018;141:e20173239.","DOI":"10.1542\/peds.2017-3239"},{"key":"2690_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1542\/peds.2023-061931","volume":"152","author":"N Shaikh","year":"2023","unstructured":"Shaikh N, Lee S, Krumbeck JA, Kurs-Lasky M. Support for the use of a new cutoff to define a positive urine culture in young children. Pediatrics. 2023;152:4.","journal-title":"Pediatrics"},{"key":"2690_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pedneo.2019.10.003","volume":"61","author":"L Walawender","year":"2020","unstructured":"Walawender L, Hains DS, Schwaderer AL. Diagnosis and imaging of neonatal UTIs. Pediatr Neonatol. 2020;61:195\u2013200.","journal-title":"Pediatr Neonatol"},{"key":"2690_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1542\/peds.2023-062883","volume":"152","author":"ER Wald","year":"2023","unstructured":"Wald ER, Eickhoff JC. Determining the best definition for a positive urine culture in young children. Pediatrics. 2023;152:4.","journal-title":"Pediatrics"},{"key":"2690_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jpurol.2022.06.004","volume":"18","author":"RF Walton","year":"2022","unstructured":"Walton RF, Shannon R, Rague JT, Chu DI, Rosoklija I, Carter LC, et al. Can diagnostic and imaging recommendations from the 2011 AAP UTI guidelines be applied to infants <2 months of age? J Pediatr Urol. 2022;18:848\u201355.","journal-title":"J Pediatr Urol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02690-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:57:30Z","timestamp":1779263850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02690-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2690"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02690-1","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Pablo S\u00e1nchez received financial support for consultation with Merck Sharpe & Dome, Kamada Pharmaceuticals, and CyanVac LLL (Blue Lake Biotechnology) that was unrelated to the study. The other authors have no conflict of interest relevant to this article to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}